Augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leading patient advocacy organization working to eliminate the challenges of rare disease. #CareAboutRARE #RareDisease Empowering the Next Generation Rare Disease Advocate. Global Genes and RARE-X officially merged into one organization December 2022 under the name Global Genes. Both organizations have been working toward the goal of empowering the next generation advocate both through their individual initiatives and their strategic partnership announced in 2021. RARE-X was born out of Global Genes after discussions with advocacy leaders, board members, partners, patients, and care partners, addressing a significant gap in access to tools, technology, and infrastructure. Hope. It’s in our genes.TM Rare Disease …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech deeptech

Targeting the biology of aging Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs. Healthspan, Aging Research, Longevity Research, Biotechnology, Aging, Age-Related Diseases, and Biology of Aging

14 similar entities Type: Startup Activities: biotech deeptech silvertech

Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in …

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Business France and its partners: promoting and supporting foreign investment in France Creators of business opportunities, throughout the world 🌍 International development is key to the development of your business. What if a meeting with Business France was what you needed to give your projects a new dimension? Our three flagship professions all have one thing in common: boosting you on the global stage!  To fast-track exports, we make the daily lives of entrepreneurs easier by providing them with the power of our network.  To generate investments and employment in France, we promote the economic attractiveness of our …

Type: Public

Striving to improve and extend patients' lives Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, ‍Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids …

51 similar entities Type: Startup Activities: biotech deeptech it services Technologies: A.I. Synthetic Biology SaaS Generative A.I.

Learning from life Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms—the vast majority of which have never been explored by science—creating a database of chemical biodiversity: the library of life. By growing, organizing, translating, and searching this unique library, Enveda learns from life’s evolved solutions to address today’s pressing medical needs. For more information on Enveda, visit enveda.com.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I.

Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. Generative A.I.

A World-Class Experience. Boston Conventions. The Boston Convention Marketing Center (BCMC) is a joint effort of the Massachusetts Convention Center Authority and the Meet Boston to market and sell the Thomas M. Menino Convention & Exhibition Center, the John B. Hynes Veterans Memorial Convention Center, and The Lawn on D. The BCMC is your single point of contact for event requirement submissions, hotel room blocks, facility contracts and site visits. Signature Boston is the name for Boston’s convention and meetings experience, and includes the Massachusetts Convention Center Authority (MCCA), Boston Convention Marketing Center (BCMC), and our partners in Boston’s hospitality …

Type: Event NGO, Think-tanks, Ed, & Culture Activities: martech

Aimed Alliance is a 501(c)(3) not-for-profit health policy organization. The mission of Aimed Alliance is to protect and Alliance for the Adoption of Innovations in Medicine (Aimed Alliance) is a nonprofit organization that works to improve health care in the United States through access to treatments and technologies. Aimed Alliance achieves this mission by developing sound, patient-centered policy recommendations with a legal and regulatory focus; collecting information and providing analysis on patient access to novel medications, measuring the value of such treatments through the improvements to length and quality of life; and collaborating with like-minded patient and professional groups with …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

We build with carbon the same way nature does. Biocement will reduce 25% of the concrete industry's emissions by 2030. At Biomason, our mission is to lead the global transition to planet-friendly construction. We are eliminating the need to emit carbon in cement production—curing the disease instead of treating the symptoms. Biomason biocement® will reduce 25% of carbon emission from the global concrete industry by 2030. #BuildBetter

3 similar entities Type: Startup Activities: constructiontech greentech cleantech Technologies: Decarbonization

Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science …

13 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: A.I. Data Analytics

Clinical-stage biopharma company focussed on the development of innovative medicines to address unmet medical need Poolbeg Pharma plc (AIM: POLB) is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company’s lead asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). As such, POLB 001 could increase the number of patients that can receive these life-saving treatments, thereby increasing the market opportunity. Poolbeg is also advancing …

4 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical

18 similar entities Type: Startup Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology

Grounded in nature, authored by AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio. artificial intelligence, machine learning, biotech, and gene editing

65 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning Generative A.I.

Save lives and reduce suffering by improving sepsis awareness and care. Sepsis Alliance Saves lives by raising awareness of sepsis as a medical emergency and support those impacted by this devastating disease. Some Facts: 1. Sepsis is the #3 cause of death in the U.S. 2. Sepsis is the #1 cost for U.S. hospitals 3. Sepsis is the leading cause of death in U.S. hospitals 4. 80% of sepsis cases arrive at the hospital 5. Sepsis is preventable and treatable in most cases About Sepsis Alliance: Sepsis Alliance is the leading sepsis organization in the U.S., working in all 50 …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

As the trade association for North Carolina’s life sciences industry, the NC Life Sciences Organization advances the industry and ecosystem and enables its members to innovate and collaborate for success in a global marketplace. NCLifeSci delivers policy and advocacy leadership, future-focused workforce development programs, industry connections and mission-driven member services.

Type: NGO, Think-tanks, Ed, & Culture Activities: entertainment

Locus Biosciences, Inc. is a biotechnology company that develops precision, engineered bacteriophage products. Locus Biosciences is a clinical-stage biotechnology company developing engineered bacteriophage products to address critical unmet medical needs in bacterial infections and immunology. The LOCUS platform combines predictive artificial intelligence and automated robotics to deliver optimized precision phage therapies that specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unaffected. Locus has strong backing from partners, having signed contracts with BARDA and CARB-X. The company recently completed the open-label portion of a Phase 2 trial assessing LBP-EC01 for the treatment of uncomplicated …

29 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, …

93 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS

At Organon, we Believe in a Better and Healthier Every Day for Every Woman. #Hereforherhealth Organon is an independent global healthcare company with a strategy to help improve the health of women throughout their lives. Organon’s diverse portfolio offers more than 70 medicines and products in women’s health and general medicines across a range of therapeutic areas. In addition to Organon’s current products, the company invests in innovative solutions and research to drive future growth prospects in women’s health. Organon is also pursuing opportunities to collaborate with biopharmaceutical partners and innovators looking to commercialise their products by leveraging its scale …

6 similar entities Type: Large company Activities: healthtech Technologies: Synthetic Biology

Activating cures so countless more individuals like Emily can survive and thrive. The Emily Whitehead Foundation, a non-profit organization, is the leading voice of the patient for advanced therapies. Founded by the parents of Emily Whitehead, the first child to receive life-saving CAR T-cell therapy, the Foundation advocates for greater access to advanced treatments and provides support to all individuals affected by cancer and rare disease. With a global network of scientists, industry collaborators, and generous contributors, the Foundation is driven to turn Emily’s survivor story into countless more survivor stories. Childhood Cancer Awareness, Immunotherapy, Pediatric Cancer Research, Cell and …

Type: Incubators & VCs

California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization. California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech

Make informed choices about your health. Our MOBILIZETM platform highlights issues affecting global healthcare. Medika Life is an online health information platform dedicated to bringing scientifically-validated and actionable health information to the world. We focus on promoting the voices of healthcare practitioners from within the industry. Our MOBILIZETM Medicine platform addresses global and local issues affecting the delivery of basic healthcare to all communities. We are outspoken in terms of equality, both within the industry - from a professional perspective - and in the delivery and accessibility of services. Our articles, mostly written by colleagues across the medical spectrum, are …

6 similar entities Type: Startup Activities: healthtech Technologies: SaaS

Specialty therapy initiation and patient support company delivering informed access and improved outcomes. AssistRx has engineered the perfect blend of technology and talent to provide life sciences organizations with an advanced therapy initiation and patient support solution that improves patient uptake, visibility and outcomes. Our balanced approach streamlines enrollment, reduces therapy disruptions and provides real-time therapy visibility through an integrated solution—delivering the informed touchpoints that simplify a complex system to enable better results for today’s patients. The AssistRx solution includes therapy initiation and patient support, patient education and adherence, and therapy insights and analytics. We have built our entire platform …

Type: Startup Activities: biotech deeptech it services Technologies: Data Analytics

The RNA Biomarker Company. Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker

6 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics

Seeking to improve lives through the curative potential of gene therapy. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with …

12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic …

5 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your daily digest of life science developments in the top bioclusters in the world. Big4Bio is the premier aggregator of developments in life sciences. Our free, daily emails focus on the “Big 4” areas of bioscience: drugs, devices, diagnostics, and digital health, with links to content gleaned from hundreds of credible industry sources. Biotechnology, News, Drug Development, Pharmaceuticals, Medical Devices, and Digital Health

Type: Media

Where life science leaders thrive AusBiotech is Australia's Biotechnology Industry Organisation, dedicated to the development, growth and prosperity of the Australian Biotechnology Industry. We deliver initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for our sector nationally and around the world. AusBiotech represents over 3,000 members working and studying in life sciences, including therapeutics, medical technology (devices and diagnostics), digital health, and agritech. With representation across the states our national network works to promote Australian research, translation, development, commercialisation and manufacturing in the national interest. The structure is a not-for-profit limited guarantee company …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Intellectual Property Law: Up to Speed. Down to Earth. At MBHB, the legal and scientific credentials of our professionals are first rate. Period. We speak the languages of law and science—and of the people we serve. One hundred percent of MBHB’s patent attorneys and technical advisors hold science or engineering degrees. Of these, nearly 50% of our patent attorneys and technical advisors hold Ph.D.s or other advanced degrees. We’re “up to speed” on the science and technology involved in IP law. But we’re also very “down to earth” in the way we choose to run our firm. As an intellectual …

Type: SMB Activities: legaltech

Coordinating the cluster of organizations dedicated to increasing the economic impact of the bioscience sector in PEI. The Prince Edward Island BioAlliance is the private sector-led not-for-profit organization that is responsible for developing and coordinating the strategy for the growth of the Prince Edward Island Bioscience Cluster. Since 2005, the BioAlliance has facilitated the work of businesses, academic and research institutions, and federal and provincial government agencies in establishing the bioscience sector as a key pillar in the economic foundation of the province and Atlantic Canada. Building from plans developed since 2005, the collaborative model of the BioAlliance has enabled …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Atlantic Canada's Bioscience Business Incubator Emergence is a business incubator dedicated to assisting start-ups and growth stage bioscience companies in efficiently bringing their products and services to market. Emergence clients benefit from access to business, technical, scientific and regulatory support services customized to meet their individual needs. This includes one-on-one and team-based mentorship; third-party consulting services; market research; legal, IP, insurance, tax and financial expertise from a network of professional service provider partners; and support accessing international networks and public and private funding and investment opportunities. Emergence serves high-potential companies wherever they are located in Canada, while also providing a …

Type: Incubators & VCs

Pioneering digital #biomarkers of neurological disease using augmented reality and machine learning. Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine. Digital Health, …

2 similar entities Type: Startup Activities: healthtech deeptech Technologies: Affective Computing A.I. A.I. - Machine Learning VR

Leading the technology revolution in clinical development. Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated to …

61 similar entities Type: Startup Activities: healthtech it services Technologies: A.I. A.I. - Machine Learning IoT SaaS

Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle

251 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

Khalifa Economic Zones Abu Dhabi KEZAD Group (Khalifa Economic Zones Abu Dhabi) is the UAE's largest operator of fully-integrated economic zones and value added business services, staff accommodation and industrial real estate solutions. Committed to creating competitive business ecosystems that encourage unprecedented growth, KEZAD Group is a key enabler of Abu Dhabi’s vision for the diversification of its economy. The Group helps build an open, agile and integrated business environment that attracts foreign and local investments to Abu Dhabi by offering outstanding market access, lower operating costs, and ease of doing business both in the region and globally. KEZAD Group's …

Type: Incubators & VCs

Working to make ME/CFS and Long Covid widely understood, diagnosable, and treatable. Donate: solvecfs.org/donate/ Solve M.E. is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other infection-associated chronic conditions and illnesses (IACCIs). Our work with the scientific, medical, and pharmaceutical communities, advocacy with government agencies, and alliances with patient groups around the world are laying the foundation for breakthroughs that can improve the lives of millions who suffer from various “long haul” diseases. Follow our page to stay up to date on the …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be …

156 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unearth Answers in Microgravity for Humanity Space Tango is an industry leader in automated systems in the pursuit of health and technology manufacturing in space. Since 2017 through a NASA Space Act Agreement, Space Tango provides facilities to support iterative R&D and manufacturing in space. Through an integrated and intuitive approach, Space Tango works alongside its diverse partner base to embrace pathways to on-orbit production yielding valuable and transformational solutions for humanity. Space Tango believes the microgravity environment is a new frontier for discovery and innovation. We are focused on creating a new global market 250 miles up in low …

Type: Startup Activities: spacetech Technologies: Synthetic Biology

A Group of Companies - Global IT/Staffing, Healthcare/Clinical/Therapy, Education/Finance, S/W Solutions & Consulting. Since 1998, Aequor has provided exceptional workforce staffing services in multiple industries. Specializing in healthcare, we place nurses, therapists, allied professionals, physicians and medical technicians, as well as staff in the life sciences, technologies and schools. We believe in making a positive impact in the lives of those we serve by inspiring people and empowering growth both personally and professionally, which makes us better as individuals and as a company. We teach our team members to nurture positive and supportive relationships with our clients and candidates by …

Type: SMB Activities: healthtech hrtech Technologies: SaaS

Research and scientific organizations committed to protecting the Bayh-Dole Act and educating policymakers about it. The Bayh-Dole Coalition is a diverse group of research and scientific organizations, as well as those directly involved in commercializing new products, committed to protecting the Bayh-Dole Act and educating policymakers about the positive impacts of the law.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

A network connected to its time, to companies, to its missions, its partners and to natural elements AIR-SEA-EARTH The CCI Midi-Pyrénées acts for the economic development of the region, alongside businesses. A place for consultation and coordination of the eight territorial chambers, the CCI Midi-Pyrénées carries out specific joint actions with them. The consular network has developed multiple services for businesses, from creation to sale or transmission. He is also a contact of choice for students and those seeking training. In 2015, the Midi-Pyrénées CCI network supported 140 companies in their energy saving approach, 3,000 new buyers and trained 1,200 …

Type: Public

Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome.

8 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T …

39 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology

55 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

evaxion.ai Evaxion A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM platform and vaccine …

Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Advancing Drug Development. Improving Lives. Together. Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech

JPEO-CBRND: Providing the warfighter with the best CBRN defense technology, equipment and medical countermeasures Welcome to the official Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) LinkedIn page. Our mission is to provide the warfighter with the best CBRN defense technology, equipment, and medical countermeasures at the right cost, at the right time, and at the right place. For more information, visit https://www.jpeocbrnd.osd.mil/ MISSION Provide integrated layered Chemical, Biological, Radiological, and Nuclear defense capabilities to the Joint Force across warfighting functions and combined Joint All-Domain Operations VISION A resilient Joint Force enabled to fight and win …

Type: Public

Producing next-generation vaccines to help protect health through partnerships and R&D. We’re focused on using our proven vaccine technology to protect health by developing our R&D assets and establishing partnerships. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our mission of ensuring broad access to our vaccines. It’s more than our job. It’s our passion. Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines r&d, business partnerships, nanoparticle protein-based technology, matrix-m, adjuvant, and vaccines

Type: Large company

Going Beyond Every Day Leading with purpose. Every day. “Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.” Emil D. Kakkis, M.D., Ph.D. Chief Executive Officer and President We have an inclusive culture of value and …

Type: Large company

Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

API manufacturer of small quantities and GMP excipients supplier Founded in 2000, Diverchim is a Small Molecule Drug Substance CDMO that specializes in complex chemistry. Diverchim offers premium services for the development and the manufacturing of small quantities APIs, from early phases to commercial. Our customers include pharma companies and emerging Biotechs involved in developing New Chemical Entities. We have a strong focus on high added-value APIs (rare diseases and orphan drugs, radiopharmaceuticals). Our capabilities include various cGMP manufacturing suites: small scale (mg to dozens of grams), kilolabs (up to a few kilos) and pilot plant (dozens of kilos). Drug …

59 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Partnering to bring your cell and gene therapies to life! ***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.*** Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi …

Type: Media SMB Activities: deeptech biotech Technologies: Synthetic Biology

AI-Powered Research for the Life Sciences Reliant AI is built to tackle the biggest information challenges in biopharma. We know that unlocking critical insights can take a tremendous amount of time and effort. Reliant AI builds the most precise applied artificial intelligence tools for the life sciences. Our technology helps biopharma professionals accelerate their work, providing them with high-quality, actionable insights in a fraction of the time without compromising quality. By combining deep expertise in reinforcement learning, natural language processing, biomedical sciences, and commercialization, we bring the power of generative AI to the most complex problems in biopharma and the …

Type: Startup Activities: it services Technologies: A.I. Generative A.I.

Climfeet insoles can heat or cool your feet without further energy than your own footsteps SoleCooler aims the market of protection of the feet and hands, against severe cold or hot weather. The principle adopted by the SoleCooler's patent is based on thermodynamics and in particular on the Carnot cycle. Air is firstly compressed. During compression, the air heats up naturally (it's like warming up as you watch your bicycle pump). Once compressed, the air is expanded through the nozzle and cools naturally (like when you deflate your car tire: the air coming out is much colder while the tire …

Type: Startup Activities: spacetech Technologies: New Materials

Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech …

46 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Your service provider in histology Since 1996, Novaxia is an independent laboratory offering customized services in histology. Whether you are a private or public research center, Novaxia accompanies you in your development projects. We work according to Good Laboratory Practices (G.L.P. Accreditation by the relevant French authority : ANSM). The range of services offered extend beyond classical histology, since today Novaxia offers services such as immunohistochemistry (IHC) and slide digitization. Our first priority is to put our knowledge and skills at your disposal. We want to understand your scientific question to ensure that we fully meet all of your expectations. …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991. ETAP-Lab is a French preclinical CRO with over 30 years' expertise in derisking research & advancing drug development for pharmaceutical and biotech companies. Our expertise covers dermatological, cardiological, neurovascular and neurological diseases thanks to our dedicated research labs. Our range of services • A portfolio of over 60 tried-and-tested in vitro and in vivo reference models. • Proof of concept & pharmacological experiments • Efficacy & safety studies Working with us • Personalized & expert advisory • Tailor-made & flexible study designs Constant innovation & …

35 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/

53 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX (NYSE America: PHGE) is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, Phage Therapies, and Pharma

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Inventing a new class of medicines using Targeted Protein Degradation Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing next-generation immunotherapies for cancer patients! Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience

Type: Startup Activities: biotech deeptech

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify …

Type: Incubators & VCs NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech

CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism. High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, and muscle health

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Curated & verified in-person professional communities: Connect, learn, and give back together! Supermomos is a community tech start-up that facilitates curated, verified, in-person communities, and brings together likeminded professionals to connect, learn, and give back together.

Type: Startup Activities: it services Technologies: SaaS

Applying machine learning in drug development Intelligencia AI uses artificial intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers combines and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning predictions to enable critical decision-making. We currently work …

73 similar entities Type: Startup Activities: biotech Technologies: A.I. A.I. - Machine Learning Data Analytics

Expanding the economic bounds of humankind. Low Earth orbit is open for business. Varda is accelerating the development of commercial space infrastructure, from in-orbit pharmaceutical processing to reliable and economical reentry capsules. Reusable rockets have lowered the cost of access to space and opened up a range of in-space activities. Now that access to space is cheap, it’s what we do there that counts. From new, life-saving pharmaceuticals to more powerful fiber optic cables, there is a world of products used on Earth today that can only be manufactured in space. Varda is accelerating innovation in the orbital economy and …

6 similar entities Type: Startup Activities: spacetech Technologies: New Materials

Delaware Prosperity Partnership (DPP) attracts, grows & retains businesses and strengthens the innovation ecosystem. The Delaware Prosperity Partnership (DPP) team is committed to supporting companies who want to grow or locate their company in Delaware. We also support building a stronger entrepreneurial and innovation ecosystem and private employers in identifying, recruiting and developing talent in Delaware. What We Do: The DPP team makes it easy for you to do business in Delaware. Whether you’re a site selector or advisor, commercial real estate developer, or C-Suite executive decision maker responsible for reviewing optimal sites to establish, expand, or relocate your company, …

Type: NGO, Think-tanks, Ed, & Culture Activities: hrtech

Vivani Medical is a pre-clinical-stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortalTM platform, Vivani’s portfolio of tiny, sub-dermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is developing two miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-115 (exenatide) and NPM-139 (semaglutide). In addition, the company is developing NPM-119, a lower dose exenatide implant for the treatment of type 2 diabetes.

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Tiziana Life Sciences LTD is a NASDAQ listed (NASDAQ:TLSA) clinical stage biotechnology company Tiziana Life Sciences LTD is a biotechnology company focused on transformational technology enabling alternative routes for immunotherapy.

Type: Startup Activities: deeptech biotech

Award-winning Scottish biopharmaceutical company, targeting annexin-A1 to treat cancers and autoimmune diseases Medannex is pioneering the targeting of annexin-A1 to provide powerful new treatment options for people impacted by cancers and autoimmune diseases. Annexin-A1 drives cancer cell growth and migration and also plays a key role in the development of several autoimmune conditions. Extensive pre-clinical data demonstrate that our first-in-class monoclonal antibody therapeutic (MDX-124) effectively blocks the action of annexin-A1. A Phase 1b clinical study is under way, in cancer patients. In parallel, we are currently preparing for further clinical studies in autoimmune diseases. Antibody development, Innovation, Biotechnology, T cell …

12 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Future of Cancer Diagnostics Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA. Clinical diagnostics and Serum testing

4 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Artificial intelligence for new drug design We are a leader in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos' proprietary and innovative generative AI solution enables the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology through the SaaS software platforms MakyaTM for generative drug design and SpayaTM for retrosynthesis, and through strategic collaborations with pharma companies where Iktos mobilizes its unique platform and …

Type: Startup Activities: deeptech biotech it services Technologies: A.I. - Deep Learning A.I. A.I. - Machine Learning Generative A.I.

Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins.

107 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials

We are Purespring. We are on a mission to radically transform the treatment of kidney diseases. Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases. biotechnology, gene therapy, and kidney diseases

35 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.

Type: SMB Activities: deeptech biotech

Scientist-to-Scientist 🔬 Porsolt is a long-established preclinical CRO, accredited by AAALAC and fully GLP compliant. 👨🏻‍🔬 With our Scientist-to-Scientist approach we support you at every step of the preclinical development process, providing the best scientific advice and offering tailored solutions to meet your needs. ✔️ We have a recognized international reputation for in vitro, ex vivo, and in vivo expertise in physiopathological models, customized procedures, histology, biomarkers, and tailored solutions for discovering treatments in over 10 different therapeutic areas. ✔️ We also offer services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in …

3 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Feel inspired Wallonia's official international portal Wallonia.be Wallonia: An open region, land of trade Wallonia is a region naturally open to the world, where languages and cultures interact. An export vocation. An extraordinary sense of welcome. A land of industrial tradition, Wallonia has forged its identity through immigration. It has a young, internationally mobile population. High schools and universities, present in the world rankings, stand out with a very significant proportion of foreign students. Sense of sharing, Accessibility, Technological know-how, and Quality of life

Type: Public

Utilizing unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year. Vaccine Development

53 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Blockchain-based traceability for the whole supply chain A blockchain based traceability solution built to enable trust, coordination, and transparency in fragmented global supply chains. traceability, food systems, seafood, agriculture, whole chain, supply chains, blockchain, data sharing, supply chain incentives, trade finance, food safety, sustainability, visibility, transparancy, and proteins

58 similar entities Type: Startup Activities: transporttech Technologies: Blockchain/Cryptocurrency

Tumor Activated Therapy: targeting Tumor Micro-Environment functional proteins to induce tumor self-destruction The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC. Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME). Seekyo’s lead compound SKY01 induces a selective tumor self-destruction: • Efficacy and safety validated in small and large animals (e.g. Dogs). • Unprecedented antitumor efficacy vs. Standards of Care • Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal...) • Low …

45 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Satisfaction comes through both work and quality of life – and Pennsylvania delivers it all. Pennsylvania is home to innovative minds, vibrant communities, and a collaborative business ecosystem dedicated to getting it done. With a fierce competitive direction, and growing momentum, Pennsylvania is freshly energized to welcome businesses from all over the country and the world. From technology to life sciences and beyond, thriving Pennsylvania companies are the driving force behind big plans that shape our future. Our businesses are powered by our 6.5-million-strong workforce, world-class higher education institutions, and targeted workforce development programs that fill our resilient talent pipelines. …

Type: Public Activities: civictech

Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Building tomorrow's antibody-drug conjugates (ADCs) Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering. Antibody Drug Conjugates and ADCs

6 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Pioneering bio||intelligence for a healthier and sustainable future. Spartha Medical harnesses AI-driven bio||intelligence to engineer advanced biopolymer-based active interfaces with inherent antimicrobial, anti-inflammatory, and biocompatible properties. Our technology platform integrates biological data analysis and adaptive AI to design dynamic microstructures that neutralize pathogens, reduce infection risks, and enhance safety across medical devices, textiles, and industrial surfaces. Aligned with the One Health framework, we address interconnected human, animal, and environmental health challenges by preventing antimicrobial resistance, mitigating cross-species infections, and promoting sustainable material innovation. Committed to the UN Sustainable Development Goals (SDGs), we advance SDG 3 (Good Health), SDG 9 (Industry …

17 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: New Materials Synthetic Biology

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and …

19 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A united team creating an innovative therapy to give a new life / vision to patients First-in-Class Drugs against ocular diseases driven by hyper-vascularization and chronic inflammation Revolutionizing severe retinal disease care with topical therapy & saving lives with groundbreaking treatments for uveal melanoma Created in 2021 and located in Nice (France), Roca Therapeutics is a spin-off from Nice University and SATT Sud Est, incubated by the PACA-Est incubator. Roca has an internationally recognized team of Directors and Advisors with a strong track record of Translational Research and Drug Development in Oncology, Ophtalmology and Immunology. Roca Therapeutics is surrounded by …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unleash the Potential of Genomic Medicine Using AI WhiteLab Genomics, a pioneer in the accelerated development of genomic medicines, sits at the intersection of artificial intelligence and biology. Founded in 2019 and supported by Y-Combinator, the company is establishing itself as a key player in genomic medicine innovation. Its proprietary AI technology enables the analysis of complex biological data and the in silico design of optimized therapeutic candidates, thus reducing development time, costs, and associated risks. WhiteLab collaborates with major pharmaceutical companies (such as Sanofi), leading academic institutions, and innovative biotech companies. WhiteLab is a member of the prestigious French …

47 similar entities Tags: FrenchTech2030 Type: Startup Activities: deeptech it services Technologies: A.I. A.I. - Machine Learning Synthetic Biology

"Ready for the Future" Leading financial services firm focused on investment and wealth management solutions. Inveready is a leading financial services firm offering alternative assets, wealth management and traditional investment funds. Founded in 2008, as a venture capital fund manager, Inveready has evolved to become one of the most active investment firms in the small and medium sized companies' segment in Spain, currently managing more than €2.1 billion. The financial group organises its services into three main business lines: ‘Alternative Assets’, which groups together different direct investment strategies (Venture Capital, Life Science Venture Debt, Strategic Public Equity, Private Equity and …

Type: Incubators & VCs

Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation

93 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The EveryLife Foundation for Rare Diseases educates, supports and amplifies the voice of rare disease patient advocates. The EveryLife Foundation for Rare Diseases is powered by the rare disease community to improve health outcomes by driving change through evidence-based policy, leading science-driven policy and regulatory research, activating the community to advocate for their rights and needs, and strengthening the rare disease community. Advocacy, Patient Engagment, Rare Diseases, and Public Policy

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence …

47 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I.

Medical Devices and IVDs Notified and Certification Body With GMED and its subsidiaries, GMED North America and GMED Asia, access all your target markets whether your MDs and IVDs are high risk or use innovative technologies. GMED is your international leading certification partner thanks to a wide scope of technical expertise (CE marking, MDSAP program, QMS certification, TCP III, MRA, etc.). Notified Body, Certification Body, Training Center... thanks to its multiple recognitions and accreditations, GMED actively contributes to advancing global healthcare. medical device certification, ISO 13485:2016, QMS compliance, Notified Body, MDSAP, Regulatory Affairs, Quality, Innovative technologies, in vitro diagnostics, EU …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Advancing agriculture in the states. Founded in 1916, NASDA is a nonpartisan, nonprofit association which represents the elected and appointed commissioners, secretaries, and directors of the departments of agriculture in all fifty states and four U.S. territories. NASDA grows and enhances agriculture by forging partnerships and creating consensus to achieve sound policy outcomes between state departments of agriculture, the federal government, and stakeholders. To learn more about NASDA, please visit www.nasda.org.

Type: NGO, Think-tanks, Ed, & Culture Activities: agritech

Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in …

91 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

A Next Generation Stem Cell Therapeutics Company Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on CymerusTM, a proprietary therapeutic stem cell platform technology. CymerusTM overcomes the challenges of other production methods by using induced pluripotent stem cells (iPSCs) and a precursor cell known as mesenchymoangioblast (MCA) to achieve economic manufacture of cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale without the limitation of multiple donors. Cynata’s lead product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology